Loading people...
Tol Trimborn is a molecular biologist and postdoctoral researcher currently based in Stanford, California. He previously earned a doctorate in molecular biology from Erasmus University Rotterdam and completed a Master of Science degree in biochemistry at Leiden University in the Netherlands. Following his graduate studies, Trimborn joined the Stanford University School of Medicine to conduct postdoctoral research specializing in oncology and advanced molecular biology. His scientific work primarily focuses on the development and advancement of novel cancer therapies through detailed molecular insights and rigorous clinical and laboratory investigation. Beyond traditional academic research, he actively bridges the gap between complex biological sciences and practical commercial applications within the health technology and startup ecosystems. Trimborn currently focuses on leveraging his extensive biotechnology expertise to support emerging oncology initiatives, early-stage health technology ventures, and broader global scientific innovation.
Tol Trimborn is Venture Partner at Bioqube Ventures.